| Pharmacology of systemic antifungal agents ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006 | 421 | 2006 |
| Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? JS Lewis, JH Jorgensen Clinical Infectious Diseases 40 (2), 280-285, 2005 | 421 | 2005 |
| Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States Y Doi, YS Park, JI Rivera, JM Adams-Haduch, A Hingwe, EM Sordillo, ... Clinical Infectious Diseases 56 (5), 641-648, 2013 | 407 | 2013 |
| Extended‐spectrum β‐lactamases: epidemiology, detection, and treatment S Nathisuwan, DS Burgess, JS Lewis Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (8 …, 2001 | 366 | 2001 |
| First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a US health care system JS Lewis, M Herrera, B Wickes, JE Patterson, JH Jorgensen Antimicrobial agents and chemotherapy 51 (11), 4015-4021, 2007 | 298 | 2007 |
| Outpatient antibiotic prescribing in the United States: 2000 to 2010 GC Lee, KR Reveles, RT Attridge, KA Lawson, IA Mansi, JS Lewis, ... BMC medicine 12, 1-8, 2014 | 281 | 2014 |
| The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes MP Weinstein, JS Lewis Journal of clinical microbiology 58 (3), 10.1128/jcm. 01864-19, 2020 | 275 | 2020 |
| Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy K Sabol, JE Patterson, JS Lewis, A Owens, J Cadena, JH Jorgensen Antimicrobial agents and chemotherapy 49 (4), 1664-1665, 2005 | 262 | 2005 |
| Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection GR Thompson III, NP Wiederhold, AC Vallor, NC Villareal, JS Lewis, ... Antimicrobial agents and chemotherapy 52 (10), 3783-3785, 2008 | 194 | 2008 |
| Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing position statements on polymyxin B and colistin clinical breakpoints MJ Satlin, JS Lewis, MP Weinstein, J Patel, RM Humphries, G Kahlmeter, ... Clinical Infectious Diseases 71 (9), e523-e529, 2020 | 164 | 2020 |
| Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used V Prakash, JS Lewis, JH Jorgensen Antimicrobial agents and chemotherapy 52 (12), 4528-4528, 2008 | 159 | 2008 |
| Refractory coccidioidomycosis treated with posaconazole GM Anstead, G Corcoran, J Lewis, D Berg, JR Graybill Clinical infectious diseases 40 (12), 1770-1776, 2005 | 159 | 2005 |
| Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy TT Ho, J Cadena, LM Childs, M Gonzalez-Velez, JS Lewis Journal of Antimicrobial Chemotherapy 67 (5), 1267-1270, 2012 | 144 | 2012 |
| Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) and blaCTX-M-15 among Extended-Spectrum-β-Lactamase-Producing E … JR Johnson, C Urban, SJ Weissman, JH Jorgensen, JS Lewis, G Hansen, ... Antimicrobial agents and chemotherapy 56 (5), 2364-2370, 2012 | 135 | 2012 |
| Outbreak investigation of COVID-19 among residents and staff of an independent and assisted living community for older adults in Seattle, Washington AC Roxby, AL Greninger, KM Hatfield, JB Lynch, TH Dellit, A James, ... JAMA internal medicine 180 (8), 1101-1105, 2020 | 130 | 2020 |
| Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus J Li, KL Echevarria, DW Hughes, JA Cadena, JE Bowling, JS Lewis Antimicrobial agents and chemotherapy 58 (9), 5117-5124, 2014 | 128 | 2014 |
| Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus J Li, KL Echevarria, DW Hughes, JA Cadena, JE Bowling, JS Lewis Antimicrobial agents and chemotherapy 58 (9), 5117-5124, 2014 | 128 | 2014 |
| Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure JS Lewis, NP Wiederhold, BL Wickes, TF Patterson, JH Jorgensen Antimicrobial agents and chemotherapy 57 (9), 4559-4561, 2013 | 118 | 2013 |
| Monotherapy or Combination Therapy? The Pseudomonas aeruginosa Conundrum KA Traugott, K Echevarria, P Maxwell, K Green, JS Lewis Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (6 …, 2011 | 103 | 2011 |
| Current options in antifungal pharmacotherapy J Mohr, M Johnson, T Cooper, JS Lewis, L Ostrosky‐Zeichner Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (5 …, 2008 | 103 | 2008 |
George R ThompsonProfessor of Medicine, Division of Infectious Diseases, University of California - DavisVerified email at ucdavis.edu
